WuXiPharmaTech Fills Two Key Leadership Positions with Internal Candidates

WuXiPharmaTech Fills Two Key Leadership Positions with Internal Candidates

January 25, 2007

    SHANGHAI, China, Jan. 25 /Xinhua-PRNewswire/ -- WuXi
PharmaTech, China's leading provider of pharmaceutical
R&D outsourcing services announced today that it has
promoted Dr. Suhan Tang and Dr. Hai Mi to Chief
Manufacturing Officer and Vice President of Corporate
Communications respectively.

    (Logo:
http://www.xprn.com.cn:9080/xprn/sa/200611271812.jpg )

    Dr. Suhan Tang joined the company in 2003 as Vice
President of Process R&D, from Schering-Plough (NYSE:
SGP), New Jersey, US.  Over the last three years, he has
been instrumental in shaping and developing the process
chemistry and scale-up manufacturing service offerings. 
Under his leadership, SynTheAll Pharmaceutical, the wholly
owned subsidiary of WuXi PharmaTech, has successfully
passed a number of client audits and won many supplier
awards.  As a result, SynTheAll has seen an increasing
number of long-term collaboration agreements with many
well-known pharmaceutical companies.

    As a former business consultant and scientist for
Pfizer (NYSE: PFE), Dr. Hai Mi joined the company two years
ago as the Senior Director of Strategic Planning.  In this
role he provided guidance on numerous executive decisions
and oversaw the Public Relations Department.  His promotion
reflects the importance of enhanced communication with all
of WuXi PharmaTech's internal and external partners.

    Both Suhan Tang and Hai Mi will report directly to Dr.
Ge Li, Chairman and CEO of the company.

    "We are very happy to have two well-qualified
internal candidates to fill the two very important
executive posts.  Both Suhan and Hai are proven leaders who
have a strong commitment to WuXi PharmaTech," commented
Dr. Li, "I am confident that both of them will continue
to build on the company's strengths, as well as effectively
provide leadership for new directions in their respective
functional areas."

    About WuXi PharmaTech Co. Ltd

    Founded in 2001, Shanghai-based WuXi PharmaTech is
China's leading drug R&D service company.  As a
research-driven and customer-focused company, WuXi
PharmaTech offers global pharmaceutical and
biopharmaceutical companies a diverse, value-added, and
fully integrated portfolio of outsourcing services ranging
from discovery chemistry, and process chemistry to service
biology, bioanalytical chemistry, and large scale GMP
manufacturing.  WuXi PharmaTech assists its global partners
in shorting the cycle and lowering the cost of drug
discovery and development by providing cost-effective and
efficient outsourcing solutions that save our clients both
time and money.  Currently, our client list consists of 19
of the top 20 pharmaceutical, and 8 of the top 10
biopharmaceutical companies.  For more information, please
visit: http://www.pharmatechs.com .
 
    For more information, please contact:

     Sherry Shao
     Tel:   [phone]
     Email: [e-mail]


SOURCE  WuXi PharmaTech., Ltd.